Beaumont Children's Hospital awarded $20,000 from CureSearch for cancer research

May 12, 2014

CureSearch for Children's Cancer has awarded a $20,000 grant to Beaumont Children's Hospital to help fund therapeutic clinical trials.

CureSearch and Beaumont believe clinical trials are essential to help children with cancer. In 2013, CureSearch supported 78 hospitals nationwide through their Clinical Trial Advancement Awards Program.

Explains Kate Gowans, M.D., section head, Pediatric Hematology and Oncology, Beaumont Children's Hospital, "We're grateful to CureSearch for this grant. CureSearch clinical trials offer hope for families whose children participate in cancer research. These studies reach patients, saving lives and changing the odds for kids today, and far into the future. This funding enables our group to open additional studies, allowing more pediatric oncology patients and their families the opportunity to participate in research trials."

Among adults, less than five percent of those with cancer are enrolled in clinical trials. Yet for children, more than 60 percent of those with cancer participate in some form of clinical research. Because clinical trials can save children's lives, CureSearch supports local hospitals, like Beaumont Children's Hospital, with Clinical Trial Advancement Awards.

Beaumont Children's Hospital doctors provide comprehensive care for pediatric oncology patients, including evaluation and treatment. They specialize in the diagnosis and treatment of blood disorders and cancers in children, using a multidisciplinary approach which includes medical, surgical and radiation oncology.
-end-
About CureSearch

CureSearch for Children's Cancer is a national nonprofit foundation whose mission is to fund and support children's cancer research and provide information and resources to all those affected by children's cancer. CureSearch raises funds for promising research conducted at more than 78 hospitals in the United States, participating in collaborative clinical trials. Through the CureSearch Acceleration Initiative and Young Investigator Program, CureSearch also funds basic and translational research that offers the greatest potential to design treatments and improve outcomes for children with difficult-to-treat cancers.Visit http://www.CureSearch.org for more information.

About Beaumont's Cancer Program

Beaumont's comprehensive cancer program combines the expertise of surgical, medical and radiation oncologists to offer cancer prevention counseling, diagnosis and treatment in hospital and community-based settings. The Beaumont Cancer Institute is one of only 51Community Clinical Oncology Programs in the country designated by the National Cancer Institute to provide patients with access to leading-edge cancer clinical research trials. Beaumont is designated as a Blue Cross Center of Distinction for the Treatment of Rare and Complex Cancers. Beaumont, Royal Oak and Troy are recognized by U.S. News & World Report as "high performing" hospitals for cancer care. Find out more at http://cancer.beaumont.edu/.

Beaumont Health System

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.